NCT05872958 - Dose Exploration Intramuscular/Intravenous Prophylaxis Pharmacokinetic Exposure Response Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 19, 2023

Primary Completion Date

August 20, 2024

Study Completion Date

August 20, 2024

Conditions

COVID-19

Interventions

DRUG

AZD3152

AZD3152 will be administered via IM injection or IV infusion, as per the assigned arms.

OTHER

Placebo

Placebo is a matching volume of 0.9% sodium chloride, will be administered via IM injection or IV infusion, as per the assigned arms.

Trial Locations (4)

Research Site, Orlando

Research Site, Cullman

Research Site, Anniston

Research Site, Scottsdale